Saffron and natural carotenoids: Biochemical activities and anti-tumor effects

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1845, Issue 1, 2014, Pages 20-30

  Bolhassani, Azam ^a   Khavari, Afshin ^a   Bathaie, S Zahra ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Biochemical immunological activities; Cancer; Carotenoids; Natural metabolites; Saffron

Indexed keywords

ALPHA TOCOPHEROL; ARSENITE SODIUM; ASTAXANTHIN; BETA CAROTENE; CANTHAXANTHIN; CAROTENOID; CROCETIN; CROCIN; CROCUS SATIVUS EXTRACT; DIMETHYLCROCETIN; DOXORUBICIN; FUCOXANTHIN; LYCOPENE; PACLITAXEL; PICROCROCIN; PLANT MEDICINAL PRODUCT; SAFRANAL; SELENIUM; SODIUM SELENITE; UNCLASSIFIED DRUG; XANTHOPHYLL; ZEAXANTHIN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; BIOCHEMISTRY; BREAST CANCER; CANCER PREVENTION; COLITIS; COLON ADENOCARCINOMA; CROCUS SATIVUS; DEPRESSION; DIET SUPPLEMENTATION; DRUG MEGADOSE; ERECTILE DYSFUNCTION; GENOTOXICITY; HUMAN; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PAPILLOMA; PHYTOCHEMISTRY; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; REVIEW; SENILE CATARACT; SKIN TUMOR; SOFT TISSUE SARCOMA; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; TH1 CELL; TH2 CELL;

AGS; BIOCHEMICAL/IMMUNOLOGICAL ACTIVITIES; CALF THYMUS DNA; CANCER; CAR; CAROTENOIDS; CAT; CATALASE; CD; CHD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCULAR DICHROISM; CONSTITUTIVE ANDROSTANE RECEPTOR; COPD; CORONARY HEART DISEASE; COX-2; CTDNA; CYCLOXYGENASE-2; DIMETHYLCROCETIN; DMC; GAP JUNCTIONAL COMMUNICATION; GASTRIC ADENOCARCINOMA; GJC; GLUTATHIONE PEROXIDASE; GPX; HEP-2; HEPATOCELLULAR CARCINOMA CELL LINE; HEPG-2; IGF-1; INSULIN GROWTH FACTOR-1; LARYNGEAL CARCINOMA CELL LINE; LDL; LOW DENSITY LIPOPROTEIN; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I; MHC-I; NATURAL KILLER CELLS; NATURAL METABOLITES; NF-ΚB; NITRIC OXIDE; NK-CELLS; NO; NUCLEAR FACTOR-ΚB; PCA; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PPARΓ; PROSTATE CANCER; RAR; REACTIVE OXYGEN SPECIES; RETINOID-LIKE RECEPTORS; ROS; SAFFRON; SOD; STEROID/XENOBIOTIC RECEPTOR/PREGNANE X RECEPTOR; SUPEROXIDE DISMUTASE; SXR/PXR; T-HELPER; TH;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAROTENOIDS; CROCUS; HUMANS; IMMUNITY;

EID: 84890059100     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2013.11.001     Document Type: Review

References (89)

1. Greenlee H. Natural products for cancer prevention. Semin. Oncol. Nurs. 2012, 28:29-44.
2. Shoshtari M.E., Sargolzaei J., Hossinimoghadam H., Farahzad J.A., Samarghandian S. Anti-tumor activity of safranal against neuroblastoma cells 2012, 1-11.
3. Lee J.E., Mannisto S., Spiegelman D., Hunter D.J., Bernstein L., Brandt P.A., Buring J.E., Cho E., English D.R., Flood A., Freudenheim J.L., Giles G.G., Giovannucci E., Hakansson N., Horn-Ross P.L., Jacobs E.J., Leitzmann M.F., Marshall J.R., McCullough M.L., Miller A.B., Rohan T.E., Ross J.A., Schatzkin A., Schouten L.J., Virtamo J., Wolk A., Zhang Sh.M., Smith-Warner S.A. Intakes of fruit, vegetables and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol. Biomarkers Prev. 2009, 18:1730-1739.
4. Oguntibeju O.O., Truter E.J., Esterhuyse A.J. The role of fruit and vegetable consumption in human health and disease prevention. Intech chapter 2013, 7:117-131.
5. Cooper A.J., Sharp S.J., Lentjes M.A.H., Luben R.N., Khaw K.T., Wareham N.J., Forouhi N.G. A prospective study of the association between quantity and variety of fruit and vegetable intake and incident type 2 diabetes. Diabetes Care 2012, 35:1293-1300.
6. Zhang S.M., Hern M.A., Olek M.J., Spiegelman D., Willett W.C., Ascherio A. Intakes of carotenoids, vitamin C and vitamin E and MS risk among two large cohorts of women. Neurology 2001, 57:75-80.
7. Cerhan J.R., Saag K.G., Merlino L.A., Mikuls T.R., Criswell L.A. Anti-oxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am. J. Epidemiol. 2003, 157:345-354.
8. Kulbacka J., Saczko J., Chwilkowska A., Choromańska A., Skołucka N. Apoptosis, free radicals and anti-oxidant defense in anti-tumor therapy 2012, 265-302. Intech.
9. Palozza P., Serini S., Di-Nicuolo F., Calviello G. Modulation of apoptotic signaling by carotenoids in cancer cells. Arch. Biochem. Biophys. 2004, 430:104-109.
10. Singh B., Prasanth P. Lycopene-secondary suppressor for cancer. I.J.R.P.C. 2012, 2:984-995.
11. Ford N.A., Erdman J.W. Are lycopene metabolites metabolically active?. A.B.P. 2012, 59:1-4.
12. Venier N.A., Colquhoun A.J., Fleshner N.E., Klotz L.H., Venkateswaran V. Lycopene enhances the anti-proliferative and pro-apoptotic effects of capsaicin in prostate cancer in vitro. J. Cancer Ther. Res. 2012, 1-9.
13. Woo H.D., Kim J. Dietary flavonoid intake and risk of stomach and colorectal cancer. World J. Gastroenterol. 2013, 19:1011-1019.
14. Chahar M.K., Sharma N., Dobhal M.P., Joshi Y.C. Flavonoids: a versatile source of anticancer drugs. Pharmacogn. Rev. 2011, 5:1-12.
15. Garcia-Lafuente A., Guillamon E., Villares A., Rostagno M.A., Martinez J.A. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm. Res. 2009, 58:537-552.
16. Bachrach Z.Y. Contribution of selected medicinal plants for cancer prevention and therapy. Sci. J. Fac. Med. Niš 2012, 29:117-123.
17. Kazemi Noureini S., Wink M. Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and hTERT down-regulation. Asian Pac. J. Cancer Prev. 2012, 13:2305-2309.
18. Vitale G., Salvioli S., Franceschi C. Oxidative stress and the ageing endocrine system. Nat. Rev. Endocrinol. 2013, 9:228-240.
19. Gismondi A., Serio M., Canuti L., Canini A. Biochemical, antioxidant and antineoplastic properties of Italian saffron (Crocus sativus L.). Am. J. Plant Sci. 2012, 3:1573-1580.
20. Kawabata K., Tung N.H., Shoyama Y., Sugie S., Mori T., Tanak T. Dietary crocin inhibits colitis and colitis-associated colorectal carcinogenesis in male ICR mice 2012, 1-13. Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine.
21. Srivastava R., Ahmed H., Dixit R.K., Saraf S.A. Crocus sativus L.: a comprehensive review. Pharmacogn. Rev. 2010, 4:200-208.
22. Javadi B., Sahebkar A., Emami S.A. A survey on saffron in major Islamic traditional medicine books. Iran J. Basic Med. Sci. 2013, 16:1-11.
23. Bathaie S.Z., Mousavi S.Z. New applications and mechanisms of action of saffron and its important ingredients. Crit. Rev. Food Sci. Nutr. 2010, 50:761-786.
24. Bolhasani A., Bathaie S.Z., Yavari I., Moosavi-Movahedi A.A., Ghaffari M. Separation and purification of some components of Iranian saffron. Asian J. Chem. 2005, 17:725-229.
25. Mohamadpour A.H., Ayati Z., Parizadeh M.R., Rajbai O., Hosseinzadeh H. Safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers. Iran J. Basic Med. Sci. 2013, 16:39-46.
26. Hosseinzadeh Namin M., Ebrahimzadeh H., Ghareyazie B., Radjabian T., Gharavi S., Tafreshi N. In vitro expression of apocarotenoid genes in Crocus sativus L. Afr. J. Biotechnol. 2009, 8:5378-5382.
27. Pfander H., Schurtenberger H. Biosynthesis of C20-carotenoids in Crocus sativus L. Phytochemistry 1982, 21:1039-1042.
28. Hosseinzadeh H. Saffron and its constituents: new pharmacological findings. Planta Med. 2009, 75:SL58.
29. Georgiadou G., Tarantilis P.A., Pitsikas N. Effects of the active constituents of Crocus sativus L., crocins, in an animal model of obsessive-compulsive disorder. Neurosci. Lett. 2012, 528:27-30.
30. Abdullaev F.I. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp. Biol. Med. 2002, 227:20.
31. Abdullaev F.I. Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.). Toxicol. in Vitro 2003, 17:751.
32. Abdullaev F.I. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Det. Preven. 2004, 28:426-432.
33. Bajbouj Kh., Schulze-Luehrmann J., Diermeier S., Amin A., Schneider-Stock R. The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines. B.M.C. Complement. Altern. Med. 2012, 12:1-9.
34. Kadian S.S., Garg M. Pharmacological effects of carotenoids: a review. I.J.P.S.R. 2012, 3:42-48.
35. Cazzonelli C.I. Carotenoids in nature: insights from plants and beyond. Funct. Plant Biol. 2011, 38:833-847.
36. Shardell M.D., Alley D.E., Hicks G.E., El-Kamary S.S., Miller R.R., Semba R.D., Ferrucci L. Low serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: The Third National Health and Nutrition Examination Survey (NHANES III). Nutr. Res. 2011, 31:178-189.
37. Mcclinton K.J. The effects of carrot carotenoids on diabetic retinopathy in type 1 diabetes mellitus. Manitoba 2012, 1-146. (A thesis).
38. Tanaka T., Shnimizu M. Cancer chemoprevention by carotenoids. Molecules 2012, 17:3202-3242.
39. Thomson C.A., Stendell-Hollis N.R., Rock Ch.L., Cussler E.C., Flatt Sh.W., Pierce J.P. Plasma and dietary carotenoids are associated with reduced oxidative stress in women previously treated for breast cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16:2008-2015.
40. Firdous A.P., Sindhu E.R., Ramnath V., Kuttan R. Anti-mutagenic and anti-carcinogenic potential of the carotenoid meso-zeaxanthin. Asian Pac. J. Cancer Prev. 2010, 11:1795-1800.
41. Yoshiko S., Hoyoku N. Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells. In vivo 2007, 21:305-310.
42. Teodoro A.J., Oliveira F.L., Martins N.B., Maia G.A., Martucci R.B., Borojevic R. Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Cancer Cell Int. 2012, 12:1-9.
43. Jain P., Pareek A., Ratan Y., Sharma S., Paliwal S. Free radicals and dietary antioxidants: a potential review. Int. J. Pharm. Sci. Rev. Res. 2013, 18:34-48.
44. Angaji S.A., Mousavi S.F., Babapour E. Antioxidants: a few key points. Ann. Biol. Res. 2012, 3:3968-3977.
45. Sariri R., Sabbaghzadeh R., Poumohamad F. In vitro antioxidant and anti-tyrosinase activity of methanol extracts from Crocus sativus flowers. Pharmacologyonline 2011, 3:1-11.
46. Makhlouf H., Saksouk M., Habib J., Chahine R. Determination of antioxidant activity of saffron taken from the flower of Crocus sativus grown in Lebanon. Afr. J. Biotechnol. 2011, 10:8093-8100.
47. McNulty H.P., Byun J., Lockwood S.F., Jacob R.F., Mason R.P. Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis. Biochim. Biophys. Acta 2007, 1768:167-174.
48. Razavi M., Hosseinzadeh H., Abnous K., Motamedshariaty V.S., Imenshahidi M. Crocin restores hypotensive effect of subchronic administration of diazinon in rats. Iran J. Basic Med. Sci. 2013, 16:64-72.
49. Khosrojerdi F., Kazemi Noureini S., Nabiuni M., Noori Z.A. Telomerase activity in breast cancer cells under treatment with crocin. Q. J. Sabzevar Univ. Med. Sci. 2012, 19:267-276.
50. Hoshyar R., Bathaie S.Z., Sadeghizadeh M. Crocin triggers the apoptosis through increasing the Bax/Bcl-2 ratio and caspase activation in human gastric adenocarcinoma, AGS, cells. DNA Cell Biol. 2013, 32:50-57.
51. Kaefer C.M., Milner J.A. The role of herbs and spices in cancer prevention. J. Nutr. Biochem. 2008, 19:347-361.
52. Hoshyar R., Bathaie S.Z., Kyani A., Mousavi M.F. Is there any interaction between telomeric DNA structures, g-quadruplex and I-motif, with saffron active metabolites?. Nucleosides Nucleotides Nucleic Acids 2012, 31:801-812.
53. Bathaie S.Z., Ashrafi M., Bolhasani A., Etemadi-Kia B., Moosavi-Movahedi A.A. Purification of carotenoids and monoterpen aldehydes from Iranian saffron and investigation of their effect on the structure of DNA, histone H1 and H1-DNA complex. Med. Plants Iran 2006, 22:85-97.
54. 15. DNA Cell Biol. 2007, 26:533-540.
55. Bolhasani A., Bathaie S.Z., Ghaffari M., Moosavi-Movahedi A.A. Interaction of monoterpene aldehydes of Iranian saffron with DNA. Modarres J. Med. Sci. 2003, 6:33-42.
56. Hoshyar R., Bathaie S.Z., Ashrafi M. Interaction of safranal and picrocrocin with ctDNA and their preferential mechanisms of binding to GC- and AT-rich oligonucleotides. DNA Cell Biol. 2008, 27:665-673.
57. Ashrafi M., Bathaie S.Z., Taghikhani M., Moosavi-Movahedi A.A. The effect of carotenoids obtained from saffron on histone H1 structure and H1-DNA interaction. Int. J. Biol. Macromol. 2005, 36:246-252.
58. Dhar A., Dhar K., Mehta S., Banerjee S., Veldhuizen P.V., Dhar G., Campbell D.R., Banerjee S.K. Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model. Mol. Cancer Ther. 2009, 8:315-323.
59. Khayatnouri M., Safavi S.E., Safarmashaei S., Babazadeh D., Mikailpourardabili B. The effect of saffron orally administration on spermatogenesis index in rat. Adv. Environ. Biol. 2011, 5:1514-1521.
60. Giaccio M. Crocetin from saffron: an active component of an ancient spice. Crit. Rev. Food Sci. Nutr. 2004, 44:155-172.
61. Sharoni Y., Danilenko M., Walfisch S., Amir H., Nahum A., Ben-Dor A., Hirsch K., Khanin M., Steiner M., Agemy L., Zango G., Levy J. Role of gene regulation in the anticancer activity of carotenoids. Pure Appl. Chem. 2002, 74:1469-1477.
62. Kim H. Inhibitory mechanism of lycopene on cytokine expression in experimental pancreatitis. Ann. N.Y. Acad. Sci. 2011, 1229:99-102.
63. Al-Qudsi F., Ayedh A. Effect of saffron on mouse embryo development. J. Am. Sci. 2012, 8:1554-1568.
64. Perez-Rodriguez L., Mougeot F., Alonso-Alvarez C., Blas J., Viñuela J., Bortolotti G.R. Cell-mediated immune activation rapidly decreases plasma carotenoids but does not affect oxidative stress in red-legged partridges (Alectoris rufa). J. Exp. Biol. 2008, 211:2155-2161.
65. Chew B.P., Park J.S. Carotenoid action on the immune response. J. Nutr. 2004, 134:257S-261S.
66. Bani S., Pandey A., Agnihotri V.K., Pathania V., Singh B. Selective Th2 upregulation by Crocus sativus: a neutraceutical spice 2011, 1-9. Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine.
67. Parizadeh M.R., Gharib F.Gh., Abbaspour A.R., Afshar J.T., Mobarhan M.G. Effects of aqueous saffron extract on nitric oxide production by two human carcinoma cell lines: hepatocellular carcinoma (HepG2) and laryngeal carcinoma (Hep2). Am. J. Clin. Pathol. 2011, 1:43-50.
68. Wiener D., Gong X., Marisiddaiah R., Rubin L. Effects of carotenoids on differential expression of scavenger receptors and cytokines in human monocyte-derived macrophage subpopulations. J. Immunol. 2010, 184:98.19.
69. Greenberg A.K., Tsay J.C., Tchou-Wong K.M., Jorgensen A., Rom W.N. Chemoprevention of lung cancer: prospects and disappointments in human clinical trials. Cancer 2013, 5:131-148.
70. Bathaie S.Z., Miri H., Mohagheghi M.A., Mokhtari-Dizaji M., Shahbazfar A.A., Hasanzadeh H. Saffron aqueous extract inhibits the chemically-induced gastric cancer progression in the Wistar albino rat. Iran J. Basic Med. Sci. 2013, 16:27-38.
71. Bakshi H., Sam S., Rozati R., Sultan P., Islam T., Rathore B., Lone Z., Sharma M., Triphati J., Saxena R.C. DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by crocin from Kashmiri saffron in a human pancreatic cancer cell line. Asian Pac. J. Cancer Prev. 2010, 11:675-679.
72. Sun Y., Xu H.J., Zhao Y.X., Wang L.Z., Sun L.R., Wang Z., Sun X.F. Crocin Exhibits Antitumor Effects on Human Leukemia HL-60 Cells In Vitro and In Vivo 2013, 1-7. Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine.
73. Aung H.H., Wang C.Z., Ni M., Fishbein A., Mehendale S.R., Xie J.T., Shoyama A.Y., Yuan C.S. Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp. Oncol. 2007, 29:175-180.
74. Li C.Y., Huang W.F., Wang Q.L., Cai F.W., Hu B., Du J.C., Wang J., Chen R., Cai X.J., Feng J., Li H.H. Crocetin induces cytotoxicity in colon cancer cells via p53-independent mechanisms. Asian Pac. J. Cancer Prev. 2012, 13:3757-3761.
75. Gutheil W.G., Reed G., Ray A., Anant S., Dhar A. Crocetin: an agent derived from saffron for prevention and therapy for cancer. Curr. Pharm. Biotechnol. 2012, 13:173-179.
76. Feizzadeh B., Tavakkol Afshari J., Rakhshandeh H., Rahimi A., Brook A., Doosti H. Cytotoxic effect of saffron stigma aqueous extract on human transitional cell carcinoma and mouse fibroblast. Urol. J. 2008, 5:161-167.
77. Abdullaev F.I., Frenkel G.D. Effect of saffron on cell colony formation and cellular nucleic acid and protein synthesis. Biofactors 1992, 3:201-204.
78. Abdullaev F.I., Frenkel G.D. The effect of saffron on intracellular DNA, RNA and protein synthesis in malignant and non-malignant human cells. Biofactors 1992, 4:43-45.
79. Tarantillis P.A., Morjani H., Polissiou M., Mafait M. Inhibition of growth and induction of differentiation of HL-60 cells by carotenoids from Crocus sativus L. Anticancer Res. 1994, 14:1913-1918.
80. Samarghandian S., Boskabady M.H., Davoodi S. Use of in vitro assays to assess the potential antiproliferative and cytotoxic effects of saffron (Crocus sativus L.) in human lung cancer cell line. Pharmacogn. Mag. 2010, 6:309-314.
81. Chryssanthi D.G., Lamari F.N., Iatrou G., Pylara A., Karamanos N.K., Cordopatis P. Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res. 2007, 27:357-362.
82. Kirkil G., Muz M.H., Sancaktar E., Kaman D., Sahin K., Kucuk O. The effect of lycopene supplementation on chronic obstructive lung disease. Nobel Med. 2012, 8:98-104.
83. Palozza P., Simone R.E., Catalano A., Mele M.C. Tomato lycopene and lung cancer prevention: from experimental to human studies. Cancer 2011, 3:2333-2357.
84. Karppi J. Measurement of carotenoids and their role in lipid oxidation and cancer. Eastern Finland Kuopio 2011, 1-96.
85. Salman H., Bergman M., Djaldetti M., Bessler H. Lycopene affects proliferation and apoptosis of four malignant cell lines. Biomed. Pharmacother. 2007, 61:366-369.
86. Engelmann N.J., Clinton S.K., Erdman J.W. Nutritional aspects of phytoene and phytofluene, carotenoid precursors to lycopene. Adv. Nutr. 2011, 2:51-61.
87. Riveron-Negrete L., Caballero-Salazar S., Ordaz-Tellez M.G., Abdullaev F. The combination of natural and synthetic agents-a new pharmacological approach in cancer chemoprevention. Proc. West. Pharmacol. Soc. 2002, 45:74-75.
88. Eid S.Y., El-Readi M.Z., Wink M. Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters. Phytomedicine 2012, 19:977-987.
89. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2002, 2:48-58.